Donadi EA - Search Results

1

Stereoselective disposition of fenoprofen in plasma and synovial fluid of patients with rheumatoid arthritis.

De Miranda Silva C, Marques MP, Barissa GR, Donadi EA, Da Silva LM, Lanchote VL. De Miranda Silva C, et al. Among authors: donadi ea. Chirality. 2007 May 5;19(4):255-63. doi: 10.1002/chir.20374. Chirality. 2007. PMID: 17299730

2

Augmented plasma and tissue kallikrein like activity in synovial fluid of patients with inflammatory articular diseases.

Volpe-Júnior N, Donadi EA, Carvalho IF, Reis ML. Volpe-Júnior N, et al. Among authors: donadi ea. Inflamm Res. 1996 Apr;45(4):198-202. doi: 10.1007/BF02285161. Inflamm Res. 1996. PMID: 8741010

3

Is HLA class II susceptibility to primary antiphospholipid syndrome different from susceptibility to secondary antiphospholipid syndrome?

Freitas MV, da Silva LM, Deghaide NH, Donadi EA, Louzada-Júnior P. Freitas MV, et al. Among authors: donadi ea. Lupus. 2004;13(2):125-31. doi: 10.1191/0961203304lu520oa. Lupus. 2004. PMID: 14995006

4

Enantioselective kinetic disposition of fenoprofen in rats with experimental diabetes or adjuvant-induced arthritis.

Cristófani Poggi J, Barissa GR, Donadi EA, Lanchote VL, Lemos dos Reis M. Cristófani Poggi J, et al. Among authors: donadi ea. Pharmacology. 2004 Oct;72(2):85-91. doi: 10.1159/000079136. Pharmacology. 2004. PMID: 15331913

5

Influence of rheumatoid arthritis in the enantioselective disposition of fenoprofen.

Barissa GR, Poggi JC, Donadi EA, Dos Reis ML, Lanchote VL. Barissa GR, et al. Among authors: donadi ea. Chirality. 2004 Nov;16(9):602-8. doi: 10.1002/chir.20065. Chirality. 2004. PMID: 15390088 Clinical Trial.

6

Pharmacodynamics, chiral pharmacokinetics, and pharmacokinetic-pharmacodynamic modeling of fenoprofen in patients with diabetes mellitus.

Poggi JC, Barissa GR, Donadi EA, Foss MC, Cunha FQ, Lanchote VL, dos Reis ML. Poggi JC, et al. Among authors: donadi ea. J Clin Pharmacol. 2006 Nov;46(11):1328-36. doi: 10.1177/0091270006293072. J Clin Pharmacol. 2006. PMID: 17050798 Clinical Trial.

7

Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations.

Magalhães MB, da Silva LM, Voltarelli JC, Donadi EA, Louzada-Junior P. Magalhães MB, et al. Among authors: donadi ea. Scand J Rheumatol. 2007 Nov-Dec;36(6):442-7. doi: 10.1080/03009740701482768. Scand J Rheumatol. 2007. PMID: 18092265

8

Determination of cyclophosphamide enantiomers in plasma by LC-MS/MS: Application to pharmacokinetics in breast cancer and lupus nephritis patients.

De Miranda Silva C, Dumêt Fernandes BJ, Marques Pereira MP, da Silva LM, Donadi EA, do Carmo Silva Matthes A, Moreira de Andrade J, Lanchote VL. De Miranda Silva C, et al. Among authors: donadi ea. Chirality. 2009 Mar;21(3):383-9. doi: 10.1002/chir.20596. Chirality. 2009. PMID: 18570312

9

Influence of glomerular filtration rate on the pharmacokinetics of cyclophosphamide enantiomers in patients with lupus nephritis.

de Miranda Silva C, Fernandes BJ, Donadi EA, Silva LM, Coelho EB, Dantas M, Marques MP, Lanchote VL. de Miranda Silva C, et al. Among authors: donadi ea. J Clin Pharmacol. 2009 Aug;49(8):965-72. doi: 10.1177/0091270009337938. Epub 2009 Jun 22. J Clin Pharmacol. 2009. PMID: 19546252 Clinical Trial.

10

Enantioselective analysis of etodolac in human plasma by LC-MS/MS: Application to clinical pharmacokinetics.

de Miranda Silva C, Rocha A, Tozatto E, da Silva LM, Donadi EA, Lanchote VL. de Miranda Silva C, et al. Among authors: donadi ea. J Pharm Biomed Anal. 2016 Feb 20;120:120-6. doi: 10.1016/j.jpba.2015.12.009. Epub 2015 Dec 12. J Pharm Biomed Anal. 2016. PMID: 26723001

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

388 results

Search Page

Filters